DAVA Investors Have Opportunity to Lead Endava plc Securities Fraud Lawsuit with SBS Law

Impact · against what's priced in

The announcement of a securities fraud class action lawsuit against Endava and Anavex Life Sciences introduces new legal liability risks. While the underlying accounting failures and reporting delays at Endava may be known, the formalization of a class action creates a specific catalyst for potential settlement costs.

AVXL−0.20

No priced-in read yet